{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:36:43Z","timestamp":1776400603057,"version":"3.51.2"},"reference-count":109,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T00:00:00Z","timestamp":1493251200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T00:00:00Z","timestamp":1493251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Cell. Biochem."],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1002\/jcb.25936","type":"journal-article","created":{"date-parts":[[2017,2,18]],"date-time":"2017-02-18T14:56:50Z","timestamp":1487429810000},"page":"2850-2864","source":"Crossref","is-referenced-by-count":16,"title":["Evaluate the Efficacy and Safety of Anti-Epileptic Medications for Partial Seizures of Epilepsy: A Network Meta-Analysis"],"prefix":"10.1002","volume":"118","author":[{"given":"Teng","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Neurology; The First Teaching Hospital of Jilin University; Changchun Jilin 130021 China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemin","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Neurology; The First Teaching Hospital of Jilin University; Changchun Jilin 130021 China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology; The First Teaching Hospital of Jilin University; Changchun Jilin 130021 China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiguo","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Neurology; The First Teaching Hospital of Jilin University; Changchun Jilin 130021 China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunkui","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Neurology; The First Teaching Hospital of Jilin University; Changchun Jilin 130021 China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,4,27]]},"reference":[{"key":"10.1002\/jcb.25936-BIB0001|jcb25936-cit-0001","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1528-1157.1994.tb02513.x","article-title":"Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: A double-blind, placebo-controlled study. The international gabapentin study group","volume":"35","author":"Anhut","year":"1994","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0002|jcb25936-cit-0002","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1528-1157.1999.tb00833.x","article-title":"Gabapentin as add-on therapy in children with refractory partial seizures: A 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin paediatric study group","volume":"40","author":"Appleton","year":"1999","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0003|jcb25936-cit-0003","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.0013-9580.2004.31203.x","article-title":"Pregabalin add-on treatment: A randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures","volume":"45","author":"Arroyo","year":"2004","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0004|jcb25936-cit-0004","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1499-1654.2000.001597.x","article-title":"Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy","volume":"41","author":"Barcs","year":"2000","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0005|jcb25936-cit-0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.eplepsyres.2010.05.008","article-title":"A comparison of pregabalin, lamotrigine, and placebo as adjunctive therapy in patients with refractory partial-onset seizures","volume":"91","author":"Baulac","year":"2010","journal-title":"Epilepsy Res"},{"issue":"Suppl 1","key":"10.1002\/jcb.25936-BIB0006|jcb25936-cit-0006","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1111\/j.1528-1157.1997.tb04514.x","article-title":"Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: The European experience","volume":"38","author":"Ben-Menachem","year":"1997","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0007|jcb25936-cit-0007","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1528-1167.2007.01188.x","article-title":"Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures","volume":"48","author":"Ben-Menachem","year":"2007","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0008|jcb25936-cit-0008","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1528-1157.2000.tb04605.x","article-title":"Efficacy and tolerability of levetiracetam 3000 mg\/d in patients with refractory partial seizures: A multicenter, double-blind, responder-selected study evaluating monotherapy. European levetiracetam study group","volume":"41","author":"Ben-Menachem","year":"2000","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0009|jcb25936-cit-0009","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.eplepsyres.2010.01.014","article-title":"Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy","volume":"89","author":"Ben-Menachem","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1002\/jcb.25936-BIB0010|jcb25936-cit-0010","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1528-1157.1996.tb00606.x","article-title":"Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures","volume":"37","author":"Ben-Menachem","year":"1996","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0011|jcb25936-cit-0011","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/seiz.2000.0380","article-title":"A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000mg daily and 4000mg daily, without titration in patients with refractory epilepsy","volume":"9","author":"Betts","year":"2000","journal-title":"Seizure"},{"key":"10.1002\/jcb.25936-BIB0012|jcb25936-cit-0012","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1212\/01.WNL.0000150932.48688.BE","article-title":"Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy","volume":"64","author":"Beydoun","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0013|jcb25936-cit-0013","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1528-1167.2010.02729.x","article-title":"A randomized, double-blind, placebo-controlled, parallel-group study of rufinamide as adjunctive therapy for refractory partial-onset seizures","volume":"52","author":"Biton","year":"2011","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0014|jcb25936-cit-0014","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1212\/01.wnl.0000187118.19221.e4","article-title":"Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures","volume":"65","author":"Biton","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0015|jcb25936-cit-0015","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/bcp.12083","article-title":"Comparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: Systematic review and network meta-analysis reveals the need for long term comparator trials","volume":"76","author":"Bodalia","year":"2013","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 1","key":"10.1002\/jcb.25936-BIB0016|jcb25936-cit-0016","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.seizure.2004.04.010","article-title":"Zonisamide clinical trials: European experience","volume":"13","author":"Brodie","year":"2004","journal-title":"Seizure"},{"key":"10.1002\/jcb.25936-BIB0017|jcb25936-cit-0017","first-page":"31","article-title":"Dose-dependent safety and efficacy of zonisamide: A randomized, double-blind, placebo-controlled study in patients with refractory partial seizures","volume":"46","author":"Brodie","year":"2005","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0018|jcb25936-cit-0018","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/j.1528-1167.2009.02160.x","article-title":"Rufinamide for the adjunctive treatment of partial seizures in adults and adolescents: A randomized placebo-controlled trial","volume":"50","author":"Brodie","year":"2009","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0019|jcb25936-cit-0019","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1053\/seiz.2000.0381","article-title":"Vigabatrin as add-on therapy for adult complex partial seizures: A double-blind, placebo-controlled multicentre study. The canadian vigabatrin study group","volume":"9","author":"Bruni","year":"2000","journal-title":"Seizure"},{"key":"10.1002\/jcb.25936-BIB0020|jcb25936-cit-0020","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/WNL.55.2.236","article-title":"Levetiracetam for partial seizures: Results of a double-blind, randomized clinical trial","volume":"55","author":"Cereghino","year":"2000","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0021|jcb25936-cit-0021","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1528-1167.2009.02496.x","article-title":"Lacosamide as adjunctive therapy for partial-onset seizures: A randomized controlled trial","volume":"51","author":"Chung","year":"2010","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0022|jcb25936-cit-0022","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/epi.12660","article-title":"Once-daily USL255 as adjunctive treatment of partial-onset seizures: Randomized phase III study","volume":"55","author":"Chung","year":"2014","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0023|jcb25936-cit-0023","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1059-1311(00)90474-6","article-title":"A randomized open-label study of gabapentin and lamotrigine in adults with learning disability and resistant epilepsy","volume":"10","author":"Crawford","year":"2001","journal-title":"Seizure"},{"key":"10.1002\/jcb.25936-BIB0024|jcb25936-cit-0024","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1212\/WNL.53.8.1724","article-title":"A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal pediatric partial seizure study group","volume":"53","author":"Duchowny","year":"1999","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0025|jcb25936-cit-0025","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1528-1167.2007.00984.x","article-title":"Eslicarbazepine acetate: A double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures","volume":"48","author":"Elger","year":"2007","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0026|jcb25936-cit-0026","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1528-1167.2008.01946.x","article-title":"Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo-controlled, parallel-group phase III study","volume":"50","author":"Elger","year":"2009","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0027|jcb25936-cit-0027","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/j.1528-1167.2005.00341.x","article-title":"Pregabalin add-on treatment in patients with partial seizures: A novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study","volume":"46","author":"Elger","year":"2005","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0028|jcb25936-cit-0028","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.eplepsyres.2009.12.003","article-title":"A 24-week multicenter, randomized, double-blind, parallel-group, dose-ranging study of rufinamide in adults and adolescents with inadequately controlled partial seizures","volume":"88","author":"Elger","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1002\/jcb.25936-BIB0029|jcb25936-cit-0029","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1212\/WNL.52.7.1338","article-title":"A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP study group","volume":"52","author":"Elterman","year":"1999","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0030|jcb25936-cit-0030","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.wnl.0000334751.89859.7f","article-title":"Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures","volume":"71","author":"Faught","year":"2008","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0031|jcb25936-cit-0031","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1212\/WNL.46.6.1684","article-title":"Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD study group","volume":"46","author":"Faught","year":"1996","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0032|jcb25936-cit-0032","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: A practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0033|jcb25936-cit-0033","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/epi.12690","article-title":"Adjunctive use of controlled-release pregabalin in adults with treatment-resistant partial seizures: A double-blind, randomized, placebo-controlled trial","volume":"55","author":"French","year":"2014a","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0034|jcb25936-cit-0034","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000003118","article-title":"Adjunctive pregabalin vs gabapentin for focal seizures: Interpretation of comparative outcomes","author":"French","year":"2016","journal-title":"Neurology."},{"key":"10.1002\/jcb.25936-BIB0035|jcb25936-cit-0035","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.0b013e3182194bd3","article-title":"Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy","volume":"76","author":"French","year":"2011","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0036|jcb25936-cit-0036","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/ane.12207","article-title":"Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR) as adjunctive therapy in patients with refractory partial-onset seizures: A randomized controlled trial","volume":"129","author":"French","year":"2014b","journal-title":"Acta Neurol Scand"},{"key":"10.1002\/jcb.25936-BIB0037|jcb25936-cit-0037","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e3182635735","article-title":"Adjunctive perampanel for refractory partial-onset seizures: Randomized phase III study 304","volume":"79","author":"French","year":"2012","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0038|jcb25936-cit-0038","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1528-1167.2012.03638.x","article-title":"Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305","volume":"54","author":"French","year":"2013","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0039|jcb25936-cit-0039","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1212\/WNL.0000000000001930","article-title":"Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial","volume":"85","author":"French","year":"2015","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0040|jcb25936-cit-0040","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1212\/01.WNL.0000068024.20285.65","article-title":"Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures","volume":"60","author":"French","year":"2003","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0041|jcb25936-cit-0041","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1212\/WNL.46.1.54","article-title":"A double-blind, placebo-controlled study of vigabatrin three g\/day in patients with uncontrolled complex partial seizures. Vigabatrin Protocol 024 Investigative Cohort","volume":"46","author":"French","year":"1996","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0042|jcb25936-cit-0042","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1212\/WNL.0000000000001558","article-title":"Perampanel efficacy and tolerability with enzyme-inducing AEDs in patients with epilepsy","volume":"84","author":"Gidal","year":"2015","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0043|jcb25936-cit-0043","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0404.2009.01218.x","article-title":"Efficacy and safety of 800 and 1200mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures","volume":"120","author":"Gil-Nagel","year":"2009","journal-title":"Acta Neurol Scand"},{"key":"10.1002\/jcb.25936-BIB0044|jcb25936-cit-0044","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1212\/01.wnl.0000217916.00225.3a","article-title":"Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures","volume":"66","author":"Glauser","year":"2006","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0045|jcb25936-cit-0045","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1111\/j.1528-1157.1999.tb01596.x","article-title":"Topiramate in medically intractable partial epilepsies: Double-blind placebo-controlled randomized parallel group trial. Korean topiramate study group","volume":"40","author":"Group","year":"1999","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0046|jcb25936-cit-0046","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/0140-6736(90)91123-R","article-title":"Gabapentin in partial epilepsy. UK gabapentin study group","volume":"335","author":"Group","year":"1990","journal-title":"Lancet"},{"key":"10.1002\/jcb.25936-BIB0047|jcb25936-cit-0047","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1034\/j.1600-0404.2002.02071.x","article-title":"Low-dose topiramate in adults with treatment-resistant partial-onset seizures","volume":"106","author":"Guberman","year":"2002","journal-title":"Acta Neurol Scand"},{"key":"10.1002\/jcb.25936-BIB0048|jcb25936-cit-0048","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/epi.12548","article-title":"Adjunctive zonisamide therapy in the long-term treatment of children with partial epilepsy: Results of an open-label extension study of a phase III, randomized, double-blind, placebo-controlled trial","volume":"55","author":"Guerrini","year":"2014","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0049|jcb25936-cit-0049","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1528-1167.2008.01951.x","article-title":"Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial","volume":"50","author":"Hal\u00e1sz","year":"2009","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0050|jcb25936-cit-0050","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1528-1167.2010.02960.x","article-title":"A randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial-onset seizures","volume":"52","author":"Halford","year":"2011","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0051|jcb25936-cit-0051","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1111\/epi.12765","article-title":"Prevention of generalized tonic-clonic seizures in refractory focal epilepsy: A meta-analysis","volume":"55","author":"Hemery","year":"2014","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0052|jcb25936-cit-0052","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration","author":"Higgins","year":"2011"},{"key":"10.1002\/jcb.25936-BIB0053|jcb25936-cit-0053","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40272-014-0072-6","article-title":"Zonisamide: A review of its use as adjunctive therapy in the management of partial seizures in pediatric patients aged >\/=6 years","volume":"16","author":"Hoy","year":"2014","journal-title":"Paediatr Drugs"},{"key":"10.1002\/jcb.25936-BIB0054|jcb25936-cit-0054","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/pcn.12300","article-title":"Efficacy and tolerability of levetiracetam as adjunctive therapy in Japanese patients with uncontrolled partial-onset seizures","volume":"69","author":"Inoue","year":"2015","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1002\/jcb.25936-BIB0055|jcb25936-cit-0055","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/2249-4847.119996","article-title":"Correlation of EEG, CT, and MRI brain with neurological outcome at 12 months in term newborns with hypoxic ischemic encephalopathy","volume":"2","author":"Jose","year":"2013","journal-title":"J Clin Neonatol"},{"key":"10.1002\/jcb.25936-BIB0056|jcb25936-cit-0056","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.yebeh.2005.07.006","article-title":"A randomized, double-blind, placebo-controlled trial of topiramate in adults with epilepsy and intellectual disability: Impact on seizures, severity, and quality of life","volume":"7","author":"Kerr","year":"2005","journal-title":"Epilepsy Behav"},{"key":"10.1002\/jcb.25936-BIB0057|jcb25936-cit-0057","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1111\/epi.13212","article-title":"A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures","volume":"56","author":"Klein","year":"2015","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0058|jcb25936-cit-0058","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1212\/WNL.0b013e318254473a","article-title":"Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures","volume":"78","author":"Krauss","year":"2012","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0059|jcb25936-cit-0059","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1002\/jcb.25936-BIB0060|jcb25936-cit-0060","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/epi.13417","article-title":"Adjunctive perampanel in adolescents with inadequately controlled partial-onset seizures: A randomized study evaluating behavior, efficacy, and safety","volume":"57","author":"Lagae","year":"2016","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0061|jcb25936-cit-0061","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1528-1167.2008.01954.x","article-title":"Pregabalin add-on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: A double-blind, randomized, placebo-controlled, multicenter trial","volume":"50","author":"Lee","year":"2009","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0062|jcb25936-cit-0062","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.eplepsyres.2014.11.015","article-title":"Efficacy and safety of perampanel in the subgroup of elderly patients included in the phase III epilepsy clinical trials","volume":"110","author":"Leppik","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1002\/jcb.25936-BIB0063|jcb25936-cit-0063","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1111\/j.1528-1167.2009.02197.x","article-title":"Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: A randomized, double-blind, placebo-controlled, noninferiority trial","volume":"50","author":"Levisohn","year":"2009","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0064|jcb25936-cit-0064","first-page":"1616","article-title":"The efficacy of leviteracetam versus carbamazepine for epilepsy: A meta-analysis","volume":"43","author":"Li","year":"2014","journal-title":"Iran J Public Health"},{"key":"10.1002\/jcb.25936-BIB0065|jcb25936-cit-0065","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1528-1157.2000.tb04607.x","article-title":"Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: A randomized, double-blind, dose titration study. GREAT Study investigators group. Gabapentin in refractory epilepsy add-on treatment","volume":"41","author":"Lindberger","year":"2000","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0066|jcb25936-cit-0066","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0920-1211(90)90099-H","article-title":"A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures","volume":"7","author":"Loiseau","year":"1990","journal-title":"Epilepsy Res"},{"key":"10.1002\/jcb.25936-BIB0067|jcb25936-cit-0067","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/11539750-000000000-00000","article-title":"Efficacy and safety of adjunctive zonisamide in adult patients with refractory partial-onset epilepsy: A randomized, double-blind, placebo-controlled trial","volume":"31","author":"Lu","year":"2011","journal-title":"Clin Drug Investig"},{"key":"10.1002\/jcb.25936-BIB0068|jcb25936-cit-0068","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/epi.12830","article-title":"Safety, tolerability, and pharmacokinetics of pregabalin in children with refractory partial seizures: A phase 1, randomized controlled study","volume":"55","author":"Mann","year":"2014","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0069|jcb25936-cit-0069","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1212\/WNL.43.11.2284","article-title":"Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. lamotrigine protocol 0.5 clinical trial group","volume":"43","author":"Matsuo","year":"1993","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0070|jcb25936-cit-0070","first-page":"CD001901","article-title":"Levetiracetam add-on for drug-resistant focal epilepsy: An updated Cochrane Review","author":"Mbizvo","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1002\/jcb.25936-BIB0071|jcb25936-cit-0071","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/epi.13279","article-title":"Cognitive effects of adjunctive perampanel for partial-onset seizures: A randomized trial","volume":"57","author":"Meador","year":"2016","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0072|jcb25936-cit-0072","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2012.10.032","article-title":"Excitotoxicity: Bridge to various triggers in neurodegenerative disorders","volume":"698","author":"Mehta","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/jcb.25936-BIB0073|jcb25936-cit-0073","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1528-1157.1994.tb02920.x","article-title":"Lamotrigine therapy for partial seizures: A multicenter, placebo-controlled, double-blind, cross-over trial","volume":"35","author":"Messenheimer","year":"1994","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0074|jcb25936-cit-0074","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.eplepsyres.2015.04.011","article-title":"Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanel","volume":"114","author":"Montouris","year":"2015","journal-title":"Epilepsy Res"},{"key":"10.1002\/jcb.25936-BIB0075|jcb25936-cit-0075","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0140-6736(14)60456-6","article-title":"Epilepsy: New advances","volume":"385","author":"Moshe","year":"2015","journal-title":"Lancet"},{"key":"10.1002\/jcb.25936-BIB0076|jcb25936-cit-0076","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1212\/01.wnl.0000277698.33743.8b","article-title":"Lamotrigine extended-release as adjunctive therapy for partial seizures","volume":"69","author":"Naritoku","year":"2007","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0077|jcb25936-cit-0077","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1212\/WNL.0b013e31822cfc90","article-title":"Incidence of epilepsy A systematic review and meta-analysis","volume":"77","author":"Ngugi","year":"2011","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0078|jcb25936-cit-0078","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/01.wnl.0000297512.18364.40","article-title":"Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures","volume":"70","author":"Noachtar","year":"2008","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0079|jcb25936-cit-0079","first-page":"344","article-title":"Diagnosis and management of the epilepsies in adults and children: Summary of updated NICE guidance","author":"Nunes","year":"2012","journal-title":"Bmj"},{"key":"10.1002\/jcb.25936-BIB0080|jcb25936-cit-0080","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.eplepsyres.2014.08.019","article-title":"Rufinamide as an adjunctive therapy for Lennox-Gastaut syndrome: A randomized double-blind placebo-controlled trial in Japan","volume":"108","author":"Ohtsuka","year":"2014","journal-title":"Epilepsy Res"},{"key":"10.1002\/jcb.25936-BIB0081|jcb25936-cit-0081","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1528-1167.2008.01817.x","article-title":"Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: A double-blind, randomized, placebo-controlled trial","volume":"50","author":"Peltola","year":"2009","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0082|jcb25936-cit-0082","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1528-1167.2008.01981.x","article-title":"Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures","volume":"50","author":"Pina-Garza","year":"2009","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0083|jcb25936-cit-0083","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1212\/01.wnl.0000259034.45049.00","article-title":"Randomized, multicenter, dose-ranging trial of retigabine for partial-onset seizures","volume":"68","author":"Porter","year":"2007","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0084|jcb25936-cit-0084","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1212\/WNL.46.6.1678","article-title":"Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE study group","volume":"46","author":"Privitera","year":"1996","journal-title":"Neurology"},{"key":"10.1002\/jcb.25936-BIB0085|jcb25936-cit-0085","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ejpn.2015.02.008","article-title":"Efficacy and safety of perampanel in adolescent patients with drug-resistant partial seizures in three double-blind, placebo-controlled, phase III randomized clinical studies and a combined extension study","volume":"19","author":"Rosenfeld","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1002\/jcb.25936-BIB0086|jcb25936-cit-0086","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/epi.12432","article-title":"Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: Results from a double-blind, randomized, placebo-controlled trial","volume":"55","author":"Ryvlin","year":"2014","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0087|jcb25936-cit-0087","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.0013-9580.2004.11403.x","article-title":"Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures","volume":"45","author":"Sackellares","year":"2004","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0088|jcb25936-cit-0088","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/jnnp.56.5.448","article-title":"Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures","volume":"56","author":"Schapel","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1002\/jcb.25936-BIB0089|jcb25936-cit-0089","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0920-1211(93)90011-U","article-title":"Zonisamide for add-on treatment of refractory partial epilepsy: A European double-blind trial","volume":"15","author":"Schmidt","year":"1993","journal-title":"Epilepsy Res"},{"key":"10.1002\/jcb.25936-BIB0090|jcb25936-cit-0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(96)00029-0","article-title":"Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy","volume":"25","author":"Sharief","year":"1996","journal-title":"Epilepsy Res"},{"key":"10.1002\/jcb.25936-BIB0091|jcb25936-cit-0091","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1528-1157.2000.tb00323.x","article-title":"Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European levetiracetam study group","volume":"41","author":"Shorvon","year":"2000","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0092|jcb25936-cit-0092","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1528-1157.1991.tb04689.x","article-title":"Double-blind study of Gabapentin in the treatment of partial seizures","volume":"32","author":"Sivenius","year":"1991","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0093|jcb25936-cit-0093","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1528-1157.1993.tb02417.x","article-title":"Outcomes of add-on treatment with lamotrigine in partial epilepsy","volume":"34","author":"Smith","year":"1993","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0094|jcb25936-cit-0094","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1528-1167.2009.02318.x","article-title":"Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials","volume":"51","author":"Sperling","year":"2010","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0095|jcb25936-cit-0095","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.eplepsyres.2014.06.004","article-title":"Efficacy of lacosamide by focal seizure subtype","volume":"108","author":"Sperling","year":"2014","journal-title":"Epilepsy Res"},{"key":"10.1002\/jcb.25936-BIB0096|jcb25936-cit-0096","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.yebeh.2016.02.041","article-title":"A long-term noninterventional safety study of adjunctive lacosamide therapy in patients with epilepsy and uncontrolled partial-onset seizures","volume":"58","author":"Steinhoff","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1002\/jcb.25936-BIB0097|jcb25936-cit-0097","first-page":"49","article-title":"Comparative efficacy of zonisamide and pregabalin as an adjunctive therapy in children with refractory epilepsy","volume":"9","author":"Taghdiri","year":"2015","journal-title":"Iran J Child Neurol"},{"key":"10.1002\/jcb.25936-BIB0098|jcb25936-cit-0098","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1528-1157.1996.tb00649.x","article-title":"Double-blind, placebo-controlled trial of topiramate (600mg daily) for the treatment of refractory partial epilepsy","volume":"37","author":"Tassinari","year":"1996","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0099|jcb25936-cit-0099","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrneurol.2014.62","article-title":"The hidden genetics of epilepsy-a clinically important new paradigm","volume":"10","author":"Thomas","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1002\/jcb.25936-BIB0100|jcb25936-cit-0100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1528-1167.2006.00372.x","article-title":"Efficacy and safety of levetiracetam (up to 2000mg\/day) in Taiwanese patients with refractory partial seizures: A multicenter, randomized, double-blind, placebo-controlled study","volume":"47","author":"Tsai","year":"2006","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0101|jcb25936-cit-0101","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archneur.55.1.56","article-title":"Tiagabine for complex partial seizures: A randomized, add-on, dose-response trial","volume":"55","author":"Uthman","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1002\/jcb.25936-BIB0102|jcb25936-cit-0102","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1528-1167.2008.01729.x","article-title":"Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures","volume":"50","author":"Wu","year":"2009","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0103|jcb25936-cit-0103","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000197109","article-title":"Efficacy and safety of levetiracetam (3, 000 mg\/Day) as an adjunctive therapy in chinese patients with refractory partial seizures","volume":"61","author":"Xiao","year":"2009","journal-title":"Eur Neurol"},{"key":"10.1002\/jcb.25936-BIB0104|jcb25936-cit-0104","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1440-1819.2006.01553.x","article-title":"Treatment of partial seizures with gabapentin: Double-blind, placebo-controlled, parallel-group study","volume":"60","author":"Yamauchi","year":"2006","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1002\/jcb.25936-BIB0105|jcb25936-cit-0105","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1528-1157.2000.tb00321.x","article-title":"A double-blind, placebo-controlled study of topiramate in adult patients with refractory partial epilepsy","volume":"41","author":"Yen","year":"2000","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0106|jcb25936-cit-0106","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/epi.12679","article-title":"Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: A randomized, double-blind, noninferiority trial","volume":"55","author":"Zaccara","year":"2014","journal-title":"Epilepsia"},{"key":"10.1002\/jcb.25936-BIB0107|jcb25936-cit-0107","volume-title":"Medical aspects of disability: a handbook for the rehabilitation professional","author":"Zaretsky","year":"2010"},{"key":"10.1002\/jcb.25936-BIB0108|jcb25936-cit-0108","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/147323001103900208","article-title":"Topiramate as an adjunctive treatment for refractory partial epilepsy in the elderly","volume":"39","author":"Zhang","year":"2011","journal-title":"J Int Med Res"},{"key":"10.1002\/jcb.25936-BIB0109|jcb25936-cit-0109","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.yebeh.2007.10.003","article-title":"Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures","volume":"12","author":"Zhou","year":"2008","journal-title":"Epilepsy Behav"}],"container-title":["Journal of Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjcb.25936","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jcb.25936","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T15:19:27Z","timestamp":1719069567000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jcb.25936"}},"subtitle":["E<scp>VALUATE<\/scp><scp>THE<\/scp>E<scp>FFICACY<\/scp><scp>AND<\/scp>S<scp>AFETY<\/scp><scp>OF<\/scp>A<scp>NTI<\/scp>-E<scp>PILEPTIC<\/scp>M<scp>EDICATIONS<\/scp>"],"short-title":[],"issued":{"date-parts":[[2017,4,27]]},"references-count":109,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"URL":"https:\/\/doi.org\/10.1002\/jcb.25936","archive":["Portico"],"relation":{},"ISSN":["0730-2312"],"issn-type":[{"value":"0730-2312","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4,27]]}}}